---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-061330"
form_type: "8-K"
ticker: null
cik: "0000811240"
company_name: "BIOLASE, INC"
filed_at: "2024-05-17T23:59:59+00:00"
generated_at: "2026-06-01T17:54:09.518114+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# BIOLASE receives Nasdaq delisting notice for negative equity of -$1.93M

## Summary
- Nasdaq notified BIOLASE on May 14, 2024 that stockholders' equity of ($1.93M) fails minimum $2.5M requirement.
- This is an additional basis for delisting and will be considered by the Nasdaq Hearings Panel.
- Company has requested a hearing before the Panel, scheduled for June 2024.

## SEC filing metadata
- accession: 0000950170-24-061330
- form_type: 8-K
- cik: 0000811240
- company_name: BIOLASE, INC
- filed_at: 2024-05-17T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/811240/000095017024061330/0000950170-24-061330-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/811240/000095017024061330/biol-20240517.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-061330
- JSON: https://secwatch.observer/filing/0000950170-24-061330.json
- Plain text: https://secwatch.observer/filing/0000950170-24-061330.txt

## Key facts
- Listing & Compliance Notices
  BIOLASE, INC received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: stockholders equity
  - Rules: 5550(b)
  source text: May 14, 2024, BIOLASE, Inc. (the “Company”) received an additional staff determination letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC notifying the Company that because its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 that was filed with the U.S. Securities and Exchange Commission on May 13, 2024 reported stockholders’ equity of ($1,934,000) as of March 31, 2024, the Company does not comply with the minimum $2,500,000 stockholders’ equity requirement for continued listing set forth in Nasdaq Listing Rule 5550(b). As a result
  evidence_url: https://www.sec.gov/Archives/edgar/data/811240/000095017024061330/0000950170-24-061330-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.